Millennium Management
INFI

Millennium Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Millennium Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-81,800
Closed -$1.43M – 3874
2013
Q3 		$1.43M Buy
+81,800
New +$1.57M ﹤0.01% 1894

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management's INFI Position: Q3 2023 in Review

Millennium Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 250,560 shares — an estimated $52.7K sold.

Millennium Management first reported a position in INFI in Q2 2013 and held it in 37 quarters. The position peaked at $21M in Q4 2014. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Millennium Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 250,560 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $52.7K.
  • Millennium Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 37 quarters.
  • Millennium Management's Infinity Pharmaceuticals, Inc. position peaked at $21M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.